Genetic Diseases in Active Gene Editing Clinical Trials and Progress (As of May 2025, based on global clinical trial data) I. Hematologic Disorders 1. Sickle Cell Disease (SCD) & β-Thalassemia Candidate Therapies: exa-cel (CTX001): Co-developed by CRISPR Therapeutics and Vertex, this therapy act … Genetic Diseases in Active Gene Editing Clinical Trials and ProgressRead more
Common Diseases
Latest Applications of Gene Editing in Genetic Disease Treatment
Latest Applications of Gene Editing in Genetic Disease Treatment (As of May 2025) Gene editing technologies are revolutionizing the treatment of genetic disorders. Below is a systematic review of recent advancements across four dimensions: technical breakthroughs, clinical applications, multi-system … Latest Applications of Gene Editing in Genetic Disease TreatmentRead more
Selecting the Optimal Treatment for Coronary Artery Disease and the Importance of Daily Health Management
Selecting the Optimal Treatment for Coronary Artery Disease and the Importance of Daily Health Management (As of May 2025) I. Strategies for Choosing CAD Treatments Effective management of coronary artery disease (CAD) requires a personalized approach that integrates disease severity, patient-specif … Selecting the Optimal Treatment for Coronary Artery Disease and the Importance of Daily Health ManagementRead more
Traditional Treatments and Best Practices for Coronary Artery Disease (CAD) (As of May 2025)
Traditional Treatments and Best Practices for Coronary Artery Disease (CAD) (As of May 2025) The traditional treatment system for coronary artery disease (CAD) encompasses pharmacological therapies, surgical interventions, minimally invasive procedures, cardiac rehabilitation, and traditional Chines … Traditional Treatments and Best Practices for Coronary Artery Disease (CAD) (As of May 2025)Read more
Gene Editing Technologies for Coronary Artery Disease (CAD) Treatment
Gene Editing Technologies for Coronary Artery Disease (CAD) Treatment (As of May 2025) The treatment of coronary artery disease (CAD) has entered an era of precision intervention through gene editing. Below is a systematic review of current gene-editing technologies applied to CAD, covering mechanis … Gene Editing Technologies for Coronary Artery Disease (CAD) TreatmentRead more
Innovative Strategies Combining Surgical and Gene-Editing Therapies for Coronary Heart Disease
Innovative Strategies Combining Surgical and Gene-Editing Therapies for Coronary Heart Disease (As of May 2025) The treatment of coronary artery disease (CAD) has evolved from traditional surgical interventions to a precision medicine era. Recent advances in combining gene-editing technologies with … Innovative Strategies Combining Surgical and Gene-Editing Therapies for Coronary Heart DiseaseRead more
Potential Risks of Gene Editing in Coronary Heart Disease
Potential Risks of Gene Editing in Coronary Heart Disease (As of May 2025) Gene editing technologies (e.g., CRISPR-Cas9, base editing) offer revolutionary strategies for treating coronary heart disease (CHD), but their clinical application faces multidimensional risks. Below is an analysis spanning … Potential Risks of Gene Editing in Coronary Heart DiseaseRead more
Comparative Analysis of Immunotherapy vs. Gene Editing Therapy (As of May 2025)
Comparative Analysis of Immunotherapy vs. Gene Editing Therapy (As of May 2025) 1. Core Mechanisms and Targets Immunotherapy Principle: Activates or enhances the patient’s immune system to recognize and kill tumor cells, primarily through engineered T cells (e.g., CAR-T) or immune checkpoint inhibit … Comparative Analysis of Immunotherapy vs. Gene Editing Therapy (As of May 2025)Read more